|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Multiple primary malignancies: a report of two cases显示文摘The diagnosis of multiple primary malignancies(MPMs) in a patient has been reported rather frequently during the past decade. Here we present two cases with three synchronous primary malignant tumors. The first patient is a 66-year-old male with synchronous colorectal cancer, renal cell carcinoma(RCC) and non-small cell lung cancer(NSCLC). The second patient is a 64-year-old female with breast cancer, transitional cell carcinoma of the ureter and endometrial cancer. MPMs seem to be diagnosed in a higher incidence than that predicted only by the influence of hazard and, whenever found, they raise questions regarding not only possible common etiologic factors or same pathogenetic mechanisms but also they cause a lot of troubles to both clinicians and patients because the therapeutic options usually become limited. | Minas Sakellakis Stavros Peroukides Gregoris Iconomou Sotirios Boumpoucheropoulos Haralabos Kalofonos | 2014 | Chinese Journal of Cancer Research2014，26，2： | 3 |
| 2 | A phase Ⅱ study of capecitabine plus oxaliplatin(XELOX):a new first-line opotion in metastatic colorectal cancer显示文摘 | Makatsoris K Kalofonos HP Aravantinos G | 2005 | Int J Gastrointest Cancer2005，35，2： | 1 |
| 3 | A phase II Study of capecitabine plus oxaliplatin ( XELOX ) : a new first-line option in metastatic colorectal cancer 显示文摘 | Makastoris T Kalofonos HP Araramtions G | 2005 | Int J Gastrointest Cancer2005，35，2： | 1 |
| 4 | Aphase II study of capecitabine plus CPT-11 : a new first-line option in me- tastatic colorectal cancer显示文摘 | Makastoris T Kalofonos HP Araramtions G | 2005 | Int Gastrointest Cancer2005，35，： | 1 |
| 5 | Monoclonal antibodies in the management of solid tumors显示文摘 | Kalofonos HP Grivas PD | 2006 | Curr Top Med Chem2006，6，16： | 1 |
| 6 | Angio- genesis and anti-angiogenic molecularly targeted therapies in malig- nant gli 显示文摘 | ARGYRIOU AA GIANNOPOULOU E KALOFONOS HP | 2009 | Ontology2009，77，1： | 1 |
| 7 | A phase II study of capecitabine plus oxaliplatin(XELOX):a new first-line option in metastatic colorectal cancer显示文摘 | Makatsoris T Kalofonos HP Aravantinos G | 2005 | Int J Gastrointest Canc-er2005，35，2： | 1 |
| 8 | Bortezomib- induced peripheral neuropathy in multiple myeloma:a comprehensive review of the literature 显示文摘 | Argyrlou AA lconomou G Kalofonos HP | 2008 | Blood2008，112，5： | 1 |
| 9 | The informational needs,satisfaction with communication,and psychological status of primary caregivers of cancer patients receiving chemotherapy显示文摘 | Vagenakis AG Kalofonos HP | 2001 | Support Care Cancer2001，9，8： | 1 |
| 10 | Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo) : a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group显示文摘 | Bamias A Aravantinos G Kalofonos C | 2003 | Oncology2003，64，2： | 1 |
| 11 | Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group显示文摘 | George Fountzilas Dimitrios Pectasides Anna Kalogera-Fountzila Dimosthenis Skarlos Haralambos P. Kalofonos Christos Papadimitriou Dimitrios Bafaloukos Stefanos Lambropoulos Savvas Papadopoulos Helen Kourea Christos Markopoulos Helen Linardou Dimitrios Mav | 2005 | Breast Cancer Research and Treatment2005，，1： | 1 |
| 12 | Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase Ⅱ study显示文摘 | Kalofonos HP Aravantinos G Kosmidis P | 2005 | Ann Oncol2005，16，6： | 1 |
| 13 | A phase Ⅲ study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer:a Hellenic Cooperative Oncology Group(HeCOG) study显示文摘 | Kalofonos HP Nicolaides C Samantas E | | 0，，： | 1 |
| 14 | Combination of topotocan and cisplatin in relapsed patients with small cell lung cancer:a phase Ⅱ study of the hellenic cooperative oncology group (HeCOG)显示文摘 | Christodoulou C Kalofonos HP Briasoulis E | 2006 | Cancer Chemother Pharmacol2006，57，2： | 1 |
| 15 | Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas显示文摘 | ARGYRIOU A A Giannopoulou E Kalofonos H P | 2009 | Oncology2009，77，1： | 1 |
| 16 | A phase Ⅱ study of capecitabine plus oxaliplatin (XELOX):a new first-line option in metastatic colorectal cancer显示文摘 | Makatsoris T Kalofonos HP Aravantinos G | 2005 | Int J Gastrointest Cancer2005，35，2： | 1 |
| 17 | Bortezomib-in- duced peripheral neuropathy in multiple myeloma: a compre- hensive review of the literature 显示文摘 | Argyriou AA Iconomou G Kalofonos HP | 2008 | Blood2008，112，5： | 1 |
| 18 | A phase Ⅱ study of capecitabine plus CPT - 11:a new first -line option in metastatic colorectal cancer 显示文摘 | Makastoris T Kalofonos HP Araramtions G | 2005 | Int Gastrointest Cancer2005，35，2： | 1 |
| 19 | Bortezomib-induced peripheral neuropathy in multiplemyeloma:a comprehensive review of the literature显示文摘 | ARGYRIOU A ICONOMOU G KALOFONOS H | 2008 | Blood2008，112，： | 1 |
| 20 | An out-patient second-1ine chemotherapy with gemcitabine and NVB in patient with NSCLC previously treated with cisplatin-based chemotherapy显示文摘 | PECTASIDEA D KALOFONOS H P SARMANTAS E | 2001 | Anticancer Res2001，21，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员